Imatinib mesylate (gleevec; STI571) monotherapy is ineffective in suppressing human anaplastic thyroid carcinoma cell growth in vitro (Q40512707)
Jump to navigation
Jump to search
scientific article published on May 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Imatinib mesylate (gleevec; STI571) monotherapy is ineffective in suppressing human anaplastic thyroid carcinoma cell growth in vitro |
scientific article published on May 2004 |
Statements
1 reference
Imatinib mesylate (gleevec; STI571) monotherapy is ineffective in suppressing human anaplastic thyroid carcinoma cell growth in vitro (English)
1 reference
Joshua M Dziba
1 reference
Kenneth B Ain
1 reference
1 May 2004
1 reference
1 reference
89
1 reference
5
1 reference
2127-2135
1 reference
Identifiers
1 reference
1 reference